A former practicing ophthalmologist, Dr. Kliman leads ophthalmology investments at InterWest Partners, a Menlo Park venture capital firm. He served as a member of the foundation's Dining in the Dark fundraising committees.
Active on the boards of many life science companies, Dr. Kliman has worked to advance the fight against blindness, most recently through his involvement in companies such as On Demand Therapeutics, Glaukos, and AGTC.
In its 40-year history, the foundation has raised about $425 million for sight-saving research. It provides patient education and support through outreach programs and 50 volunteer-led chapters across the country.